Zoletil 50, (25 mg/ml+25 mg/ml) lyophilisate and solvent for solution for injection for dogs and cats
Zoletil 50, (25 mg/ml+25 mg/ml) lyophilisate and solvent for solution for injection for dogs and cats
Authorised
- Zolazepam hydrochloride
- Tiletamine hydrochloride
Product identification
Medicine name:
Zoletil 50, (25 mg/ml+25 mg/ml) lyophilisate and solvent for solution for injection for dogs and cats
Active substance:
- Zolazepam hydrochloride
- Tiletamine hydrochloride
Target species:
-
Dog
-
Cat
Route of administration:
-
Intravenous use
-
Intramuscular use
Product details
Active substance and strength:
-
Zolazepam hydrochloride125.00/milligram(s)1.00Vial
-
Tiletamine hydrochloride125.00/milligram(s)1.00Vial
Pharmaceutical form:
-
Lyophilisate and solvent for solution for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QN01AX99
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Bulgaria
Available in:
-
Bulgaria
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
- Virbac
Responsible authority:
- Bulgarian Food Safety Authority
Authorisation number:
- 0022-2046
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 8/10/2025
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 26/01/2026
Labelling
This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 8/10/2025